Revaclear 400 dialyzers. Indicated for treatment of chronic and acute renal failure by hemod...
FDA Recall #Z-0764-2023 — Class II — November 23, 2022
Product Description
Revaclear 400 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.
Reason for Recall
Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak
Recalling Firm
Baxter Healthcare Corporation — Deerfield, IL
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Devices
Product Quantity
1,140,096 units
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, China, Australia, New Zealand, Austria, Egypt, France, Germany, Ireland, Italy, Morocco, Qatar, Saudi Arabia, South Africa, Spain, United Kingdom, Bahamas, Barbados, Belize, Bermuda, Colombia, Dominican Republic, Ecuador, Guatemala, Honduras, Mexico, Panama, St. Thomas, Trinidad and Tobago.
Code Information
No distribution in the USA. Product Code: 114749M; All lot numbers from C422202401 C422227201
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medical device immediately and consult your healthcare provider. Contact the recalling firm for instructions on return or replacement. If you experienced an adverse event, inform your doctor.